Novapeutics was found to develop a curative for curing type 2 diabetes. Later, one of the original co-founder, Frank Leu, re-imagined and transformed Novapeutics to be a therapeutics company that not in pursuit of using novel pharmacological agents, but also truly understand the root of the diseases of interest (not only for diabetes) to restore health.